Merck Rewards Shareholders with First Dividend Increase in 7 Years

Merck & Co (NYSE:MRK) announced a 10.5% dividend hike for investors.  The company will raise its quarterly dividend from 38 cents per share to 42 cents per share.  It is Merck’s first dividend hike in 7 years.  Shareholders of record as of December 15 will be paid the dividend on January 9.

Here’s how Merck & Co and other high dividend pharma stocks are trading:

  • Merck & Co. Inc. (NYSE:MRK): The shares recently traded at $34.60, up $0.81, or 2.4%. Its market capitalization is $106.60 billion. They have traded in a 52-week range of $29.47 to $37.65. Volume today was 7,030,536 shares versus a 3-month average volume of 17,987,600 shares. The company’s trailing P/E is 25.37, while trailing earnings are $1.36 per share. The company pays a dividend of $1.52 per share for a dividend yield of 4.40%. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis. Get the most recent company news and stock data here >>
  • Pfizer Inc. (NYSE:PFE): The shares recently traded at $19.61, up $0.27, or 1.4%. Its market capitalization is $153.04 billion. They have traded in a 52-week range of $16.25 to $21.45. Volume today was 7,942,864 shares versus a 3-month average volume of 50,904,900 shares. The company’s trailing P/E is 13.66, while trailing earnings are $1.44 per share. The company pays a dividend of $0.80 per share for a dividend yield of 4.00%. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines. Get the most recent company news and stock data here >>
  • Bristol-Myers Squibb Company (NYSE:BMY): The shares recently traded at $31.08, up $0.11, or 0.36%. Its market capitalization is $52.67 billion. They have traded in a 52-week range of $24.97 to $33.27. Volume today was 1,608,394 shares versus a 3-month average volume of 14,793,900 shares. The company’s trailing P/E is 16.03, while trailing earnings are $1.94 per share. The company pays a dividend of $1.32 per share for a dividend yield of 4.20%. About the company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Get the most recent company news and stock data here >>
  • Abbott Laboratories (NYSE:ABT): The shares recently traded at $53.27, up $0.33, or 0.62%. Its market capitalization is $82.98 billion. They have traded in a 52-week range of $45.07 to $55.61. Volume today was 827,113 shares versus a 3-month average volume of 9,648,810 shares. The company’s trailing P/E is 18.37, while trailing earnings are $2.90 per share. The company pays a dividend of $1.92 per share for a dividend yield of 3.50%. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors. Get the most recent company news and stock data here >>
  • Eli Lilly & Co. (NYSE:LLY): The shares recently traded at $37.31, down $0.05, or 0.13%. Its market capitalization is $41.56 billion. They have traded in a 52-week range of $33.46 to $39.78. Volume today was 1,360,247 shares versus a 3-month average volume of 9,369,840 shares. The company’s trailing P/E is 8.92, while trailing earnings are $4.18 per share. The company pays a dividend of $1.96 per share for a dividend yield of 5.00%. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products. Get the most recent company news and stock data here >>

Don’t Miss: This Asset Manager’s New Top Healthcare Stock Position Changes.